This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
public health | 603 |
extracellular vesicles | 575 |
summary conclusion | 561 |
influenza virus | 541 |
cystic fibrosis | 450 |
results suggest | 446 |
epithelial cells | 364 |
cell lines | 364 |
gene expression | 354 |
present study | 338 |
influenza viruses | 322 |
research funds | 269 |
cell line | 265 |
electron microscopy | 263 |
hong kong | 258 |
health care | 257 |
flow cytometry | 244 |
pandemic influenza | 244 |
western blot | 244 |
ng ml | 222 |
mg kg | 218 |
respiratory syndrome | 213 |
cell culture | 211 |
significantly higher | 205 |
seasonal influenza | 202 |
nervous system | 201 |
stem cells | 200 |
graduate school | 189 |
immune response | 185 |
infected cells | 182 |
united states | 179 |
amino acid | 178 |
cell death | 176 |
performed using | 172 |
mrna expression | 172 |
virus infection | 171 |
mean age | 171 |
protein expression | 160 |
significantly increased | 158 |
important role | 156 |
significant differences | 156 |
medical center | 155 |
data suggest | 153 |
cell proliferation | 153 |
endothelial cells | 152 |
results indicate | 151 |
cell types | 151 |
risk factors | 150 |
previous studies | 150 |
previously described | 150 |
acute respiratory | 147 |
derived evs | 146 |
blood pressure | 146 |
cell surface | 145 |
previously reported | 140 |
growth factor | 140 |
stem cell | 138 |
lung disease | 138 |
avian influenza | 138 |
nanoparticle tracking | 138 |
antiviral activity | 137 |
determine whether | 137 |
time pcr | 137 |
mass spectrometry | 136 |
tracking analysis | 134 |
ko mice | 134 |
control group | 134 |
western blotting | 133 |
statistically significant | 133 |
immune responses | 132 |
significant difference | 132 |
world war | 130 |
lung function | 129 |
mass production | 129 |
nerve conduction | 129 |
cancer cells | 128 |
significantly reduced | 128 |
national institute | 127 |
infectious diseases | 126 |
plasma membrane | 126 |
years old | 125 |
mouse model | 125 |
spinal cord | 124 |
pg ml | 122 |
gestational age | 121 |
respiratory tract | 120 |
wild type | 119 |
pseudomonas aeruginosa | 119 |
airway epithelial | 119 |
significantly lower | 119 |
united kingdom | 118 |
peripheral neuropathy | 117 |
smooth muscle | 117 |
clinical trials | 117 |
healthy controls | 117 |
findings suggest | 116 |
doc id | 115 |
cord uid | 115 |
severe acute | 114 |
new york | 114 |
may contribute | 114 |
peripheral blood | 110 |
pregnant women | 110 |
inflammatory response | 110 |
transmission electron | 110 |
body weight | 109 |
disaster management | 107 |
total number | 105 |
peripheral nerve | 105 |
dependent manner | 104 |
social distancing | 104 |
breast cancer | 103 |
significantly different | 102 |
differentially expressed | 101 |
time points | 101 |
neuropathic pain | 100 |
total rna | 100 |
influenza vaccine | 99 |
blood flow | 99 |
two groups | 99 |
significant increase | 99 |
room temperature | 99 |
innate immune | 98 |
current study | 98 |
blood samples | 98 |
significantly decreased | 98 |
central nervous | 97 |
brain injury | 97 |
real time | 97 |
health promotion | 96 |
influenza infection | 96 |
social media | 96 |
porcine circovirus | 96 |
oxidative stress | 96 |
feb feb | 96 |
mar mar | 96 |
first time | 95 |
mg ml | 94 |
statistical analysis | 94 |
may also | 94 |
recent studies | 93 |
bone marrow | 92 |
world health | 92 |
measured using | 91 |
orf protein | 90 |
analysis revealed | 89 |
cancer cell | 89 |
intensive care | 88 |
immune cells | 88 |
cell cultures | 88 |
mrna levels | 88 |
health organization | 88 |
developing countries | 87 |
protein levels | 87 |
positive cells | 87 |
blot analysis | 87 |
molecular mechanisms | 86 |
research institute | 86 |
binding protein | 85 |
thermo fisher | 85 |
ex vivo | 85 |
transcription factor | 85 |
may play | 84 |
usa introduction | 84 |
logistic regression | 84 |
epithelial cell | 84 |
expression levels | 84 |
virus replication | 83 |
high levels | 83 |
type i | 83 |
schwann cells | 82 |
serum samples | 82 |
mdck cells | 82 |
progenitor cells | 82 |
culture media | 82 |
extracellular vesicle | 81 |
cell cycle | 81 |
white matter | 81 |
first trimester | 81 |
determined using | 81 |
fisher scientific | 81 |
exclusion chromatography | 80 |
international collaboration | 79 |
culture medium | 79 |
taken together | 79 |
immune system | 79 |
capsid protein | 78 |
disease severity | 78 |
results show | 78 |
prostate cancer | 78 |
university school | 77 |
wild hemp | 77 |
poorly understood | 76 |
also found | 76 |
extracellular matrix | 76 |
syndrome virus | 76 |
university hospital | 76 |
care unit | 75 |
cell migration | 75 |
fold increase | 75 |
increased risk | 75 |
disaster response | 75 |
wdnhbe cells | 74 |
cidp patients | 74 |
health systems | 74 |
mesenchymal stem | 74 |
scanning electron | 73 |
porcine reproductive | 73 |
derived exosomes | 73 |
infectious disease | 73 |
previously shown | 73 |
adverse events | 73 |
three times | 73 |
endothelial cell | 73 |
weight loss | 72 |
chronic inflammatory | 72 |
inflammatory cytokines | 72 |
inflammatory demyelinating | 72 |
influenza pandemic | 72 |
human airway | 72 |
airway epithelium | 71 |
swine influenza | 71 |
previous study | 71 |
study period | 71 |
one patient | 71 |
fetal growth | 71 |
ovarian cancer | 71 |
ca i | 71 |
viral rna | 70 |
results showed | 70 |
least one | 70 |
nerve fibers | 70 |
neuronal activity | 70 |
signaling pathways | 69 |
treated cells | 69 |
animal models | 69 |
well plates | 69 |
derived extracellular | 69 |
inhibitory effect | 69 |
gene therapy | 69 |
analysis showed | 68 |
age groups | 68 |
cells expressing | 68 |
recipient cells | 68 |
infected individuals | 68 |
highly pathogenic | 67 |
circovirus type | 67 |
infected cases | 67 |
pulmonary function | 67 |
may provide | 67 |
large number | 67 |
commonly used | 66 |
size exclusion | 66 |
also observed | 66 |
amino acids | 66 |
bronchial epithelial | 66 |
cerebral cortex | 65 |
cd cd | 65 |
study design | 65 |
viral infection | 65 |
amniotic fluid | 65 |
days post | 65 |
protein kinase | 65 |
purkinje cells | 65 |
san diego | 65 |
new public | 65 |
ob gyn | 64 |
size distribution | 64 |
wide range | 64 |
time rt | 64 |
positive control | 64 |
per year | 63 |
open access | 63 |
conditioned medium | 63 |
analyzed using | 62 |
human influenza | 62 |
brain science | 62 |
adult patients | 61 |
median age | 61 |
viral replication | 61 |
umbilical cord | 61 |
hippocampal neurons | 61 |
widely used | 61 |
gbs patients | 61 |
prefrontal cortex | 61 |
pulmonary disease | 61 |
two patients | 60 |
confocal microscopy | 60 |
conditioned media | 60 |
data show | 60 |
may lead | 60 |
protein synthesis | 60 |
alveolar macrophages | 60 |
antibody response | 60 |
nitric oxide | 60 |
treated mice | 60 |
disease control | 60 |
density gradient | 60 |
increased expression | 59 |
knockout mice | 59 |
novel coronavirus | 59 |
applied biosystems | 59 |
significant decrease | 59 |
reverse transcription | 59 |
mechanisms underlying | 59 |
side effects | 59 |
way anova | 58 |
neural stem | 58 |
life technologies | 58 |
nerve injury | 58 |
standard deviation | 58 |
animal model | 58 |
many countries | 58 |
conduction studies | 58 |
syndrome coronavirus | 58 |
outcome measures | 58 |
significant reduction | 58 |
specific antibodies | 58 |
visual cortex | 57 |
confirmed cases | 57 |
long term | 57 |
ev isolation | 57 |
neurocritical care | 57 |
cell adhesion | 57 |
goat anti | 57 |
informed consent | 57 |
critical role | 57 |
staphylococcus aureus | 57 |
lung injury | 56 |
molecular weight | 56 |
cohort study | 56 |
closely related | 56 |
african americans | 56 |
endoplasmic reticulum | 56 |
inflammatory responses | 56 |
monoclonal antibodies | 56 |
viral infections | 56 |
health system | 56 |
transgenic mice | 55 |
fold higher | 55 |
medical school | 55 |
cells treated | 55 |
growth factors | 55 |
future studies | 55 |
stromal cells | 55 |
two different | 55 |
statistical significance | 55 |
bovine serum | 55 |
preliminary results | 55 |
wt mice | 55 |
university graduate | 55 |
commercially available | 55 |
monte carlo | 55 |
ns activated | 54 |
cardiac arrest | 54 |
cerebrospinal fluid | 54 |
medical care | 54 |
synaptic transmission | 54 |
subarachnoid hemorrhage | 54 |
phylogenetic analysis | 54 |
european countries | 54 |
cell viability | 54 |
medical university | 54 |
target cells | 54 |
trophoblast cells | 53 |
glial cells | 53 |
cortical neurons | 53 |
coronavirus disease | 53 |
sciatic nerve | 53 |
fold change | 53 |
receptor antagonist | 53 |
airway epithelia | 53 |
infected pigs | 53 |
key role | 53 |
disease progression | 53 |
university medical | 52 |
cancer patients | 52 |
primary human | 52 |
also showed | 52 |
monoclonal antibody | 52 |
early stage | 52 |
skeletal muscle | 52 |
assessed using | 52 |
antibody titers | 52 |
nutritional status | 52 |
transcription factors | 52 |
within hours | 52 |
recent years | 52 |
dorsal root | 52 |
gel electrophoresis | 52 |
sample size | 52 |
nucleic acid | 52 |
small rna | 52 |
mutant mice | 52 |
cell type | 52 |
electron microscope | 51 |
pulmonary exacerbation | 51 |
preterm birth | 51 |
respiratory viruses | 51 |
control mice | 51 |
electron beam | 51 |
patients compared | 51 |
total protein | 51 |
viruses isolated | 51 |
lung tissue | 51 |
time point | 51 |
type ii | 51 |
risk factor | 50 |
differential expression | 50 |
analysis using | 50 |
life satisfaction | 50 |
quality control | 50 |
osaka univ | 50 |
cell responses | 50 |
higher levels | 50 |
national health | 50 |
well known | 50 |
influenza vaccines | 49 |
muc ac | 49 |
studies showed | 49 |
particle size | 49 |
results demonstrate | 49 |
ml min | 49 |
pregnant rats | 49 |
active intervention | 49 |
menstrual cycle | 49 |
preterm delivery | 49 |
data indicate | 49 |
antibody responses | 49 |
energy transitions | 48 |
lung cancer | 48 |
significantly associated | 48 |
better understand | 48 |
kyoto university | 48 |
isolated using | 48 |
north america | 48 |
patients receiving | 48 |
fatty acids | 48 |
muscle cells | 48 |
feb mar | 48 |
escherichia coli | 48 |
small extracellular | 47 |
differential ultracentrifugation | 47 |
reverse transcriptase | 47 |
neutralizing antibodies | 47 |
mononuclear cells | 47 |
surface markers | 47 |
primary care | 47 |
south korea | 47 |
per well | 47 |
negative control | 47 |
clinical trial | 47 |
health services | 47 |
three different | 47 |
human myometrium | 46 |
severe disease | 46 |
viral load | 46 |
situ hybridization | 46 |
general population | 46 |
synaptic plasticity | 46 |
growth restriction | 46 |
preterm labor | 46 |
high level | 46 |
tooth disease | 46 |
pulmonary exacerbations | 46 |
pyramidal neurons | 46 |
mortality rates | 46 |
samples collected | 46 |
cells using | 46 |
sensory neurons | 46 |
significant changes | 46 |
pathogenic avian | 46 |
blood cells | 46 |
new zealand | 46 |
peripheral nervous | 45 |
axonal neuropathy | 45 |
data analysis | 45 |
significantly greater | 45 |
quantitative rt | 45 |
research center | 45 |
dendritic cells | 45 |
traumatic brain | 45 |
lung epithelial | 45 |
scientific research | 45 |
odds ratio | 45 |
genes involved | 45 |
patients admitted | 45 |
described previously | 44 |
crucial role | 44 |
body mass | 44 |
motor neurons | 44 |
fev predicted | 44 |
health insurance | 44 |
ev markers | 44 |
demyelinating polyneuropathy | 44 |
airway surface | 44 |
study showed | 44 |
west nile | 44 |
potential role | 44 |
medical research | 44 |
hours post | 44 |
magnetic resonance | 44 |
well tolerated | 44 |
vaccine strain | 44 |
evs derived | 44 |
kg day | 44 |
clinical features | 44 |
preliminary data | 44 |
last years | 44 |
isolated evs | 44 |
expression level | 44 |
weeks gestation | 43 |
ev cargo | 43 |
bibliometric analysis | 43 |
nk cells | 43 |
mice showed | 43 |
val met | 43 |
first wave | 43 |
plasma samples | 43 |
influenza vaccination | 43 |
significantly inhibited | 43 |
ae log | 43 |
ms ms | 43 |
antiviral drugs | 43 |
investigated whether | 43 |
viral shedding | 43 |
family members | 43 |
developed countries | 43 |
liquid biopsy | 43 |
clinical data | 43 |
birth weight | 42 |
nlrp inflammasome | 42 |
signaling pathway | 42 |
johns hopkins | 42 |
data suggests | 42 |
mouse models | 42 |
may represent | 42 |
middle east | 42 |
cmt patients | 42 |
cftr expression | 42 |
times higher | 42 |
activated mazf | 42 |
patients without | 42 |
median nerve | 42 |
results indicated | 42 |
gene transfer | 42 |
porcine epidemic | 42 |
fbp ko | 42 |
whole blood | 42 |
nucleic acids | 42 |
intercellular communication | 42 |
fetal membranes | 42 |
schwann cell | 42 |
healthy subjects | 42 |
intravenous immunoglobulin | 41 |
tumour cells | 41 |
drug resistance | 41 |
cap protein | 41 |
tissue culture | 41 |
th century | 41 |
science institute | 41 |
fatty acid | 41 |
cytokine production | 41 |
three patients | 41 |
granule cells | 41 |
treated animals | 41 |
will provide | 41 |
showed significant | 41 |
south africa | 41 |
mg dl | 41 |
host cells | 41 |
gnrh neurons | 41 |
control cells | 41 |
ev release | 41 |
even though | 41 |
dmd patients | 41 |
cd null | 40 |
apical membrane | 40 |
also significantly | 40 |
cftr gene | 40 |
protein content | 40 |
wound healing | 40 |
mortality rate | 40 |
deficient mice | 40 |
two weeks | 40 |
drg neurons | 40 |
transfected cells | 40 |
human bronchial | 40 |
financial stress | 40 |
viral diseases | 40 |
early diagnosis | 40 |
null mice | 40 |
time course | 40 |
hippocampal slices | 40 |
expression pattern | 40 |
functional outcome | 40 |
investigate whether | 40 |
recently reported | 40 |
also known | 40 |
patients received | 40 |
like particles | 40 |
pyramidal cells | 40 |
status epilepticus | 40 |
differential centrifugation | 40 |
regression analysis | 40 |
recombinant proteins | 39 |
surface expression | 39 |
retrospective study | 39 |
vero cells | 39 |
age group | 39 |
protein microarrays | 39 |
fibrosis foundation | 39 |
evs isolated | 39 |
clinical symptoms | 39 |
highly expressed | 39 |
high throughput | 39 |
dentate gyrus | 39 |
tissue sections | 39 |
cytopathic effect | 39 |
year old | 39 |
intracellular ca | 39 |
rna sequencing | 39 |
nmda receptor | 39 |
respiratory symptoms | 39 |
primary outcome | 39 |
important roles | 39 |
fluorescent protein | 38 |
cesarean section | 38 |
cell communication | 38 |
patients treated | 38 |
low levels | 38 |
insulin resistance | 38 |
liver disease | 38 |
factors associated | 38 |
confidence interval | 38 |
one week | 38 |
different types | 38 |
nile virus | 38 |
pandemic virus | 38 |
data demonstrate | 38 |
olfactory bulb | 38 |
different countries | 38 |
rat brain | 38 |
expression profiles | 38 |
high risk | 38 |
may result | 38 |
buffered saline | 37 |
two distinct | 37 |
neurite outgrowth | 37 |
evs released | 37 |
isolation methods | 37 |
four patients | 37 |
heart rate | 37 |
see chapter | 37 |
lower limbs | 37 |
folic acid | 37 |
hela cells | 37 |
clinical practice | 37 |
microarray analysis | 37 |
pcr analysis | 37 |
virus isolation | 37 |
health status | 37 |
model system | 37 |
previously demonstrated | 37 |
cell biology | 37 |
serum levels | 37 |
disaster prevention | 37 |
cd expression | 37 |
upper respiratory | 37 |
immunized mice | 37 |
study aimed | 37 |
pc cells | 37 |
diabetes mellitus | 37 |
connective tissue | 36 |
sputum samples | 36 |
national university | 36 |
analysed using | 36 |
second world | 36 |
well plate | 36 |
cftr protein | 36 |
apoptotic neutrophils | 36 |
cerebral ischemia | 36 |
randomly selected | 36 |
molecular mechanism | 36 |
fetal brain | 36 |
cervical ripening | 36 |
live attenuated | 36 |
membrane protein | 36 |
influenza surveillance | 36 |
nerve regeneration | 36 |
osaka university | 36 |
clinical signs | 36 |
human lung | 36 |
new cases | 36 |
cell survival | 36 |
weight gain | 36 |
per group | 36 |
first world | 36 |
national institutes | 36 |
red blood | 36 |
mouse igg | 36 |
mass index | 36 |
infected mice | 36 |
findings indicate | 36 |
binding site | 36 |
exponential growth | 36 |
brain regions | 36 |
clinically relevant | 36 |
study group | 36 |
european union | 36 |
increased levels | 36 |
motor neuropathy | 36 |
matched controls | 36 |
study demonstrates | 36 |
mean fev | 36 |
ca region | 35 |
cells may | 35 |
expressing cells | 35 |
women undergoing | 35 |
flow rate | 35 |
peripheral nerves | 35 |
adhesion molecule | 35 |
study provides | 35 |
also increased | 35 |
surveillance system | 35 |
like receptor | 35 |
infected patients | 35 |
respiratory syncytial | 35 |
local governments | 35 |
clinical studies | 35 |
brain tissue | 35 |
may help | 35 |
much higher | 35 |
small fiber | 35 |
gene segments | 35 |
alveolar epithelial | 35 |
cpg odns | 34 |
washed three | 34 |
treatment groups | 34 |
normal human | 34 |
inclusion criteria | 34 |
largely unknown | 34 |
type diabetes | 34 |
cross section | 34 |
nagoya university | 34 |
proteomic analysis | 34 |
studies suggest | 34 |
bronchoalveolar lavage | 34 |
clinical samples | 34 |
los angeles | 34 |
high frequency | 34 |
community health | 34 |
physical activity | 34 |
ev subpopulations | 34 |
dt framework | 34 |
cell function | 34 |
circuit current | 34 |
rabies virus | 34 |
human cells | 34 |
chain reaction | 34 |
mouse brain | 34 |
plasma evs | 34 |
antiviral agents | 34 |
mucociliary clearance | 34 |
expression patterns | 34 |
may reflect | 34 |
conduction block | 34 |
studies will | 34 |
chloride channel | 34 |
early stages | 34 |
membrane potential | 33 |
southern china | 33 |
viral particles | 33 |
vast majority | 33 |
examined whether | 33 |
copy number | 33 |
early detection | 33 |
war ii | 33 |
fast set | 33 |
trade war | 33 |
virus infections | 33 |
chicken eggs | 33 |
poor prognosis | 33 |
expression changes | 33 |
mice immunized | 33 |
cord blood | 33 |
remains unclear | 33 |
central role | 33 |
cardiovascular disease | 33 |
per capita | 33 |
one year | 33 |
regression model | 33 |
currently available | 33 |
peripheral neuropathies | 33 |
bacterial infection | 33 |
potential therapeutic | 33 |
pathway analysis | 33 |
made available | 33 |
rat hippocampal | 33 |
chart review | 33 |
critical care | 33 |
flow cytometric | 33 |
expression analysis | 33 |
time period | 33 |
kyoto univ | 33 |
san francisco | 33 |
income countries | 33 |
derived macrophages | 33 |
immunodeficiency virus | 33 |
three groups | 33 |
economic growth | 33 |
drug delivery | 33 |
young adults | 33 |
cleavage site | 33 |
among patients | 32 |
day post | 32 |
recent study | 32 |
hypertonic saline | 32 |
circumstantial changes | 32 |
fluorescence microscopy | 32 |
transmembrane conductance | 32 |
cftr function | 32 |
cells infected | 32 |
vaccinia virus | 32 |
healthy volunteers | 32 |
signal transduction | 32 |
may affect | 32 |
polymerase chain | 32 |
will discuss | 32 |
antiviral drug | 32 |
age years | 32 |
antibiotic treatment | 32 |
motor performance | 32 |
copyright holder | 32 |
sequence analysis | 32 |
programmed cell | 32 |
compared using | 32 |
mental health | 32 |
mainland china | 32 |
less likely | 32 |
action potentials | 32 |
quantified using | 32 |
may serve | 32 |
will help | 32 |
type mice | 32 |
cell membrane | 32 |
tohoku univ | 32 |
surface liquid | 32 |
quantitative analysis | 32 |
scientific production | 32 |
symptom onset | 32 |
north carolina | 32 |
blocking buffer | 32 |
significantly elevated | 32 |
uncleavable mazf | 32 |
guinea pigs | 32 |
hopkins university | 32 |
quantitative pcr | 32 |
clinical course | 32 |
previous reports | 32 |
female mice | 32 |
cells transfected | 31 |
results suggested | 31 |
culture supernatant | 31 |
light chain | 31 |
small evs | 31 |
culture supernatants | 31 |
cell growth | 31 |
nasal epithelium | 31 |
miu ml | 31 |
syncytial virus | 31 |
poor outcome | 31 |
rbc units | 31 |
bl mice | 31 |
global health | 31 |
pcr products | 31 |
management system | 31 |
well understood | 31 |
tokyo metropolitan | 31 |
adhesion molecules | 31 |
protein cargo | 31 |
several studies | 31 |
early pregnancy | 31 |
therapeutic potential | 31 |
small number | 31 |
quantitative real | 31 |
virus strains | 31 |
cftr activity | 31 |
novel therapeutic | 31 |
zika virus | 31 |
ad libitum | 31 |
studies using | 31 |
antimicrobial activity | 31 |
data support | 31 |
saudi arabia | 31 |
related circumstantial | 31 |
positively correlated | 31 |
expression vector | 31 |
nsi research | 31 |
conjugated goat | 31 |
final concentration | 31 |
conductance regulator | 31 |
considered significant | 31 |
also performed | 31 |
single nucleotide | 31 |
growth rate | 31 |
past years | 31 |
airway inflammation | 31 |
growth cone | 31 |
tohoku university | 31 |
vascular endothelial | 31 |
wt cells | 31 |
dose dependent | 31 |
free medium | 30 |
wildlife trade | 30 |
vaccine candidates | 30 |
infected animals | 30 |
functional recovery | 30 |
climate change | 30 |
old male | 30 |
two types | 30 |
i sc | 30 |
nerve biopsy | 30 |
infection control | 30 |
control measures | 30 |
retrospective cohort | 30 |
innate immunity | 30 |
six months | 30 |
linear regression | 30 |
pulmonary hypertension | 30 |
health research | 30 |
chapel hill | 30 |
intracranial pressure | 30 |
light scattering | 30 |
muscular dystrophy | 30 |
channel activity | 30 |
surface marker | 30 |
conduction velocities | 30 |
registered cultivars | 30 |
hospital admission | 30 |
hek cells | 30 |
normal pregnancy | 30 |
tyrosine kinase | 30 |
positive samples | 30 |
control animals | 30 |
nerve fiber | 30 |
ethics committee | 30 |
neutrophil elastase | 30 |
therapeutic targets | 30 |
substantia nigra | 30 |
see table | 30 |
sequencing data | 30 |
bacterial infections | 30 |
lower respiratory | 30 |
outer membrane | 30 |
life expectancy | 30 |
natural history | 30 |
neuronal cell | 29 |
sural nerve | 29 |
neural activity | 29 |
eoc cells | 29 |
granted medrxiv | 29 |
essential role | 29 |
tested positive | 29 |
play important | 29 |
observational study | 29 |
different concentrations | 29 |
east respiratory | 29 |
basal ganglia | 29 |
generation sequencing | 29 |
protein microarray | 29 |
ev production | 29 |
human brain | 29 |
assay kit | 29 |
asl volume | 29 |
dendritic spines | 29 |
cellular uptake | 29 |
positive correlation | 29 |
host cell | 29 |
year period | 29 |
und die | 29 |
version posted | 29 |
chronic obstructive | 29 |
eventually infected | 29 |
tumour microenvironment | 29 |
also identified | 29 |
different cell | 29 |
family history | 29 |
author funder | 29 |
epidemic diarrhea | 29 |
present work | 29 |
peer review | 29 |
clinical presentation | 29 |
brain function | 29 |
inflammatory cytokine | 29 |
blood mononuclear | 29 |
viral proteins | 29 |
drinking water | 29 |
brain barrier | 29 |
retrospective analysis | 29 |
better understanding | 29 |
vivo studies | 29 |
receptor expression | 29 |
axonal degeneration | 29 |
human endometrial | 29 |
virus titers | 29 |
respiratory distress | 29 |
platelet activation | 29 |
first step | 29 |
recombinant protein | 29 |
granulosa cells | 28 |
antiviral treatment | 28 |
two days | 28 |
projection neurons | 28 |
whole genome | 28 |
sh tc | 28 |
study also | 28 |
decidual cells | 28 |
saharan africa | 28 |
evaluated using | 28 |
ns protease | 28 |
selected countries | 28 |
renal function | 28 |
skin biopsy | 28 |
rna viruses | 28 |
viral protein | 28 |
gabaergic neurons | 28 |
allow us | 28 |
obstructive pulmonary | 28 |
human disease | 28 |
new therapeutic | 28 |
fully understood | 28 |
ec values | 28 |
viral genome | 28 |
direct contact | 28 |
th cells | 28 |
two years | 28 |
fibrosis transmembrane | 28 |
cells compared | 28 |
secretory phase | 28 |
pidd patients | 28 |
study suggests | 28 |
table shows | 28 |
skin biopsies | 28 |
virus ns | 28 |
autosomal dominant | 28 |
international collaborations | 28 |
scanning vol | 28 |
embryonated chicken | 28 |
pilot study | 28 |
high dose | 28 |
fetal plasma | 28 |
fetal bovine | 28 |
genome sequencing | 28 |
life science | 28 |
higher risk | 28 |
global research | 28 |
demyelinating neuropathy | 28 |
lymph node | 28 |
human immunodeficiency | 28 |
acute lung | 28 |
resistant virus | 28 |
binding domain | 28 |
membrane vesicles | 28 |
multiple sclerosis | 28 |
expressed genes | 28 |
neurodegenerative diseases | 28 |
significant correlation | 28 |
hiv infection | 28 |
respiratory illness | 28 |
transgene expression | 28 |
genomic dna | 28 |
one hundred | 28 |
jja vit | 28 |
uric acid | 28 |
supplement iv | 28 |
human placenta | 28 |
ha gene | 28 |
riken brain | 28 |
results obtained | 28 |
results provide | 27 |
useful tool | 27 |
action potential | 27 |
increased significantly | 27 |
clinical characteristics | 27 |
adjuvanted vaccine | 27 |
biological activity | 27 |
human endometrium | 27 |
state university | 27 |
inhibitory effects | 27 |
type cftr | 27 |
diagnostic criteria | 27 |
tax reform | 27 |
provide evidence | 27 |
statistical analyses | 27 |
hcv infected | 27 |
rat model | 27 |
antibiotic therapy | 27 |
dopaminergic neurons | 27 |
myelin protein | 27 |
therapeutic agents | 27 |
proinflammatory cytokines | 27 |
three independent | 27 |
circulating evs | 27 |
patient population | 27 |
th percentile | 27 |
data showed | 27 |
trump administration | 27 |
patients may | 27 |
follicular fluid | 27 |
data obtained | 27 |
examined using | 27 |
breeding lines | 27 |
respiratory disease | 27 |
locomotor activity | 27 |
fat mass | 27 |
also demonstrated | 27 |
mast cells | 27 |
therapeutic target | 27 |
highly conserved | 27 |
villous explants | 27 |
protein level | 27 |
protein markers | 27 |
resistant staphylococcus | 27 |
auditory cortex | 27 |
health sciences | 27 |
western blots | 27 |
therapeutic strategies | 27 |
small molecule | 27 |
exosomes isolated | 27 |
data sets | 27 |
exosomes derived | 27 |
hippocampal ca | 27 |
placebo group | 27 |
resistant strains | 27 |
nl min | 27 |
ciliated cells | 26 |
also used | 26 |
ae lg | 26 |
high degree | 26 |
tight junctions | 26 |
fetal sheep | 26 |
viral dna | 26 |
communicable diseases | 26 |
generated using | 26 |
vitro model | 26 |
leading cause | 26 |
health issues | 26 |
health outcomes | 26 |
analysis demonstrated | 26 |
cells showed | 26 |
plasma levels | 26 |
early onset | 26 |
inhibitory peptide | 26 |
induced cell | 26 |
high mortality | 26 |
world wars | 26 |
pivotal role | 26 |
culture system | 26 |
lavage fluid | 26 |
mice treated | 26 |
environmental factors | 26 |
estrogen receptor | 26 |
across countries | 26 |
light microscopy | 26 |
protective immunity | 26 |
binding sites | 26 |
still unclear | 26 |
first report | 26 |
conduction velocity | 26 |
necrosis factor | 26 |
pulmonary fibrosis | 26 |
ion transport | 26 |
mechanism underlying | 26 |
will allow | 26 |
one case | 26 |
gbs disability | 26 |
st century | 26 |
infection cases | 26 |
lung inflammation | 26 |
receptive field | 26 |
whole cell | 26 |
linked immunosorbent | 26 |
hlamp gag | 26 |
resonance imaging | 26 |
specific antibody | 26 |
normal pregnancies | 26 |
pdm virus | 26 |
patients presenting | 26 |
virus transmission | 26 |
human umbilical | 26 |
igg antibodies | 26 |
liquid interface | 26 |
within days | 26 |
tract infections | 26 |
adverse effects | 26 |
patients presented | 26 |
muscle weakness | 26 |
authors declare | 26 |
wistar rats | 26 |
significantly less | 26 |
evidence suggests | 26 |
guinea pig | 26 |
acute exacerbation | 25 |
ang ii | 25 |
respiratory infection | 25 |
atp release | 25 |
term potentiation | 25 |
cd cells | 25 |
ge healthcare | 25 |
keloid fibroblasts | 25 |
molecular biology | 25 |
patients underwent | 25 |
life cycle | 25 |
blood cell | 25 |
clinical outcome | 25 |
second largest | 25 |
correlation coefficient | 25 |
different levels | 25 |
also show | 25 |
intracerebral hemorrhage | 25 |
receptor binding | 25 |
pluripotent stem | 25 |
plasma volume | 25 |
also investigated | 25 |
medium containing | 25 |
stably expressing | 25 |
first study | 25 |
nasal washes | 25 |
study shows | 25 |
infectious agents | 25 |
sensory neuropathy | 25 |
high sensitivity | 25 |
rna polymerase | 25 |
previously published | 25 |
influenza season | 25 |
diabetic neuropathy | 25 |
pediatric patients | 25 |
plasma exchange | 25 |
cpg odn | 25 |
immune cell | 25 |
increasing concentrations | 25 |
motor nerve | 25 |
cannabis sativa | 25 |
cerebral artery | 25 |
sialic acid | 25 |
human plasma | 25 |
mechanical ventilation | 25 |
fibrosis patients | 25 |
late gestation | 25 |
vehicle control | 25 |
federal government | 25 |
cells well | 25 |
like illness | 25 |
rabies vaccines | 25 |
high yield | 25 |
using two | 25 |
rna extraction | 25 |
low dose | 25 |
cell signaling | 25 |
colorectal cancer | 25 |
prospective study | 25 |
patient care | 25 |
human myometrial | 25 |
expression profile | 25 |
neural network | 25 |
cells cultured | 25 |
next generation | 25 |
rna replication | 25 |
also tested | 25 |
similar results | 25 |
iv antibiotics | 25 |
fetal weight | 25 |
using anti | 25 |
adipose tissue | 25 |
control subjects | 25 |
cell lysates | 25 |
maternal plasma | 25 |
purkinje cell | 25 |
ca pyramidal | 25 |
arterial blood | 25 |
cross sections | 25 |
demyelinating polyradiculoneuropathy | 24 |
neurological disorders | 24 |
economic policy | 24 |
based assay | 24 |
brain development | 24 |
human serum | 24 |
cell differentiation | 24 |
plaque assay | 24 |
per patient | 24 |
mdck pf | 24 |
large numbers | 24 |
will require | 24 |
conducted using | 24 |
severe cases | 24 |
wide variety | 24 |
vitro studies | 24 |
beneficial effects | 24 |
pandemic vaccine | 24 |
significant improvement | 24 |
laser scanning | 24 |
treated group | 24 |
cited references | 24 |
cell activation | 24 |
may explain | 24 |
brain death | 24 |
root ganglia | 24 |
marked increase | 24 |
showed increased | 24 |
old man | 24 |
serial dilutions | 24 |
treatment group | 24 |
binding proteins | 24 |
obstetrics gynecology | 24 |
cerebral blood | 24 |
tissue samples | 24 |
infrared spectroscopy | 24 |
signalling pathways | 24 |
glutamate receptor | 24 |
small molecules | 24 |
receptor signaling | 24 |
paraffin embedded | 24 |
five patients | 24 |
information processing | 24 |
inflammatory mediators | 24 |
od value | 24 |
studies revealed | 24 |
animal care | 24 |
sweat chloride | 24 |
associated proteins | 24 |
high fat | 24 |
assay using | 24 |
reported cases | 24 |
independent experiments | 24 |
induced apoptosis | 24 |
trophoblast cell | 24 |
associated protein | 24 |
medical treatment | 24 |
insect cells | 24 |
transforming growth | 24 |
cognitive function | 24 |
adaptive immune | 24 |
data also | 24 |
preventive measures | 24 |
data collection | 24 |
matched healthy | 24 |
also present | 24 |
jan jan | 24 |
north american | 24 |
many patients | 24 |
group showed | 24 |
case fatality | 24 |
resistant viruses | 24 |
yellow fever | 24 |
ev numbers | 24 |
jan feb | 24 |
null animals | 24 |
patch clamp | 24 |
culture conditions | 24 |
conduction study | 24 |
single cell | 24 |
sciatic nerves | 24 |
significant change | 24 |
secondary antibody | 24 |
transplant recipients | 24 |
patients undergoing | 24 |
viral loads | 24 |
human respiratory | 24 |
den usa | 24 |
die usa | 24 |
identified using | 23 |
aea levels | 23 |
prrsv infection | 23 |
induced sputum | 23 |
heat shock | 23 |
pregnant mice | 23 |
bile acid | 23 |
creative commons | 23 |
health policy | 23 |
placental tissue | 23 |
protective effect | 23 |
human macrophages | 23 |
lawsonia intracellularis | 23 |
cell index | 23 |
school closure | 23 |
fetal lung | 23 |
pcr using | 23 |
daily deaths | 23 |
neural activities | 23 |
sensory nerve | 23 |
sensory loss | 23 |
lymph nodes | 23 |
following treatment | 23 |
master mix | 23 |
highly variable | 23 |
maternal age | 23 |
days later | 23 |
nuclear translocation | 23 |
target genes | 23 |
gnrh ii | 23 |
study using | 23 |
diarrhea virus | 23 |
industrialized countries | 23 |
vaccine development | 23 |
chikungunya virus | 23 |
asl height | 23 |
detected using | 23 |
sodium channel | 23 |
throughput screening | 23 |
particles ml | 23 |
results demonstrated | 23 |
urine samples | 23 |
type iii | 23 |
eight patients | 23 |
possible role | 23 |
mammalian cells | 23 |
related genes | 23 |
promoter activity | 23 |
two decades | 23 |
studies indicate | 23 |
using specific | 23 |
newborn screening | 23 |
mesenchymal stromal | 23 |
normal controls | 23 |
may improve | 23 |
class i | 23 |
inflammatory cells | 23 |
neurotrophic factor | 23 |
weeks old | 23 |
passive immunotherapy | 23 |
different time | 23 |
tandem mass | 23 |
result suggests | 23 |
pcv infection | 23 |
immunohistochemical analysis | 23 |
mice exhibited | 23 |
respiratory infections | 23 |
optical density | 23 |
intrauterine growth | 23 |
acute phase | 23 |
written informed | 23 |
biomarker discovery | 23 |
among women | 23 |
national cancer | 23 |
clinical applications | 23 |
origin influenza | 23 |
relatively low | 23 |
pcr assay | 23 |
submucosal glands | 23 |
analysis identified | 23 |
mrsa strains | 23 |
median time | 23 |
primary cultures | 23 |
newborn offspring | 23 |
cerebral edema | 23 |
enrichment methods | 23 |
lower limb | 23 |
flow cytometer | 23 |
care systems | 23 |
middle cerebral | 23 |
vivo model | 23 |
reactive oxygen | 23 |
carpal tunnel | 23 |
proteins involved | 23 |
na genes | 23 |
medical sciences | 23 |
neuronal differentiation | 23 |
intracellular calcium | 23 |
neuronal cells | 23 |
human urine | 22 |
predictive value | 22 |
sars coronavirus | 22 |
antiviral research | 22 |
viral sequences | 22 |
host defense | 22 |
cell bodies | 22 |
electrical stimulation | 22 |
school students | 22 |
treatment response | 22 |
serum albumin | 22 |
gradient centrifugation | 22 |
total infected | 22 |
virus type | 22 |
without controls | 22 |
also confirmed | 22 |
chicken embryos | 22 |
across different | 22 |
tested using | 22 |
first line | 22 |
tumour growth | 22 |
autosomal recessive | 22 |
patients diagnosed | 22 |
cell carcinoma | 22 |
strongly associated | 22 |
signalling pathway | 22 |
keio univ | 22 |
randomly assigned | 22 |
broad range | 22 |
single ev | 22 |
slowly progressive | 22 |
morphological changes | 22 |
done using | 22 |
diffuse alveolar | 22 |
time series | 22 |
high resolution | 22 |
small sample | 22 |
mice infected | 22 |
controlled trial | 22 |
health needs | 22 |
least two | 22 |
unclear whether | 22 |
labeled cells | 22 |
showed similar | 22 |
ev protein | 22 |
ev preparations | 22 |
care system | 22 |
twentieth century | 22 |
cov infection | 22 |
higher rates | 22 |
human placental | 22 |
negative controls | 22 |
disability score | 22 |
mice compared | 22 |
significant increases | 22 |
electron microscopic | 22 |
significantly correlated | 22 |
gene encoding | 22 |
liquid chromatography | 22 |
pcr amplification | 22 |
evs may | 22 |
grand island | 22 |
care facilities | 22 |
clinical outcomes | 22 |
functional significance | 22 |
cultured cells | 22 |
herpes simplex | 22 |
mouse enteroids | 22 |
adult mice | 22 |
three weeks | 22 |
incubation period | 22 |
cell counts | 22 |
glucose tolerance | 22 |
food intake | 22 |
tested whether | 22 |
research group | 22 |
body composition | 22 |
greater number | 22 |
high concentrations | 22 |
image analysis | 22 |
economic development | 22 |
foster city | 22 |
relative abundance | 22 |
sociotechnical systems | 22 |
significant effect | 22 |
highly sensitive | 22 |
neurological examination | 22 |
reverse genetics | 22 |
lung transplant | 22 |
ae ae | 22 |
riken bsi | 22 |
old woman | 22 |
differences among | 22 |
clinically stable | 22 |
united nations | 22 |
trend towards | 22 |
fear memory | 22 |
scientific globalism | 22 |
control study | 22 |
i will | 22 |
specific cd | 22 |
gene delivery | 22 |
may cause | 22 |
motor function | 22 |
potential biomarkers | 22 |
ill patients | 22 |
motor cortex | 22 |
dna damage | 22 |
differential gene | 22 |
million people | 22 |
capsid igg | 22 |
derived ev | 22 |
neutralizing antibody | 21 |
present results | 21 |
despite enhanced | 21 |
evs showed | 21 |
brain activity | 21 |
distal leg | 21 |
clinical research | 21 |
lung tissues | 21 |
patients infected | 21 |
response plan | 21 |
disease duration | 21 |
virus infected | 21 |
refractory status | 21 |
bacterial cells | 21 |
vaccine production | 21 |
persistent infection | 21 |
infectious virus | 21 |
vice versa | 21 |
outcome measure | 21 |
team members | 21 |
brain tissues | 21 |
will also | 21 |
will continue | 21 |
persistent pulmonary | 21 |
open reading | 21 |
intracranial hemorrhage | 21 |
disease caused | 21 |
tumor necrosis | 21 |
internal genes | 21 |
secondary antibodies | 21 |
ic values | 21 |
infectious bronchitis | 21 |
converting enzyme | 21 |
us department | 21 |
hospital mortality | 21 |
short term | 21 |
major role | 21 |
general public | 21 |
like viruses | 21 |
group compared | 21 |
nmda receptors | 21 |
healthy donors | 21 |
relatively high | 21 |
small rnas | 21 |
calculated using | 21 |
antiviral therapy | 21 |
ev surface | 21 |
sum score | 21 |
missense mutations | 21 |
term care | 21 |
acquired mrsa | 21 |
results support | 21 |
international license | 21 |
clinical use | 21 |
managed care | 21 |
polyclonal antibodies | 21 |
reproductive sciences | 21 |
cells per | 21 |
reported previously | 21 |
bd biosciences | 21 |
tokyo medical | 21 |
imperial college | 21 |
nasopharyngeal swabs | 21 |
case report | 21 |
dawley rats | 21 |
social sciences | 21 |
ionizing radiation | 21 |
fold greater | 21 |
acid use | 21 |
per day | 21 |
cfu ml | 21 |
medical history | 21 |
household transmission | 21 |
pharmaceutical sciences | 21 |
risk perceptions | 21 |
autoimmune diseases | 21 |
erk activation | 21 |
pregnancies complicated | 21 |
na absorption | 21 |
national hospital | 21 |
old female | 21 |
low level | 21 |
major cause | 21 |
four different | 21 |
motor learning | 21 |
human fetal | 21 |
virulence factors | 21 |
previously identified | 21 |
dna vaccine | 21 |
body temperature | 21 |
chronic diseases | 21 |
influenza strains | 21 |
three months | 21 |
chronic disease | 21 |
relative expression | 21 |
studies demonstrated | 21 |
also shown | 21 |
reporter gene | 21 |
dorsal horn | 21 |
pandemic potential | 21 |
chronic infection | 21 |
uterine emg | 21 |
mdck cell | 21 |
previous work | 21 |
rem sleep | 21 |
significantly improved | 21 |
pelvic organ | 21 |
umbilical vein | 21 |
best practices | 21 |
control groups | 21 |
phase i | 21 |
remains unknown | 21 |
virus vaccine | 21 |
axonal transport | 21 |
oxygen species | 21 |
critically ill | 21 |
allowed us | 21 |
chronic lung | 21 |
ev populations | 21 |
stable cell | 21 |
transgenic mouse | 21 |
clinical phenotype | 21 |
coding region | 21 |
surround suppression | 21 |
observations suggest | 21 |
ev proteins | 21 |
physiological role | 20 |
santa cruz | 20 |
one day | 20 |
ns protein | 20 |
carbon dioxide | 20 |
motor axonal | 20 |
macrophage polarization | 20 |
rabies vaccine | 20 |
hepg cells | 20 |
newly identified | 20 |
cftr mutations | 20 |
hand hygiene | 20 |
global pandemic | 20 |
pregnancy outcome | 20 |
latin america | 20 |
related diabetes | 20 |
gold standard | 20 |
genes associated | 20 |
vascular smooth | 20 |
size range | 20 |
cell derived | 20 |
duchenne muscular | 20 |
case study | 20 |
exome sequencing | 20 |
health authorities | 20 |
log tcid | 20 |
cells grown | 20 |
cold war | 20 |
axonal loss | 20 |
ae ml | 20 |
sectional study | 20 |
adult population | 20 |
full length | 20 |
sanger sequencing | 20 |
retrospective review | 20 |
amyotrophic lateral | 20 |
local disaster | 20 |
human subjects | 20 |
caesarean section | 20 |
nagoya univ | 20 |
class ii | 20 |
cell numbers | 20 |
natural killer | 20 |
hepatocellular carcinoma | 20 |
central government | 20 |
clinical isolates | 20 |
alveolar damage | 20 |
antiviral compounds | 20 |
clinical specimens | 20 |
ich volume | 20 |
different stages | 20 |
working memory | 20 |
potential difference | 20 |
institutional affiliations | 20 |
mouse anti | 20 |
retrospective chart | 20 |
lateral sclerosis | 20 |
detection limit | 20 |
set infa | 20 |
results will | 20 |
recently identified | 20 |
susceptible population | 20 |
viral titers | 20 |
drug discovery | 20 |
severe tbi | 20 |
medical science | 20 |
exosome secretion | 20 |
high expression | 20 |
using primers | 20 |
hcv rna | 20 |
gene ontology | 20 |
cell detachment | 20 |
obtained using | 20 |
health problems | 20 |
virus isolates | 20 |
emerging infectious | 20 |
igg anti | 20 |
bat species | 20 |
lung pathology | 20 |
twice daily | 20 |
transmitter release | 20 |
highly effective | 20 |
root ganglion | 20 |
respiratory diseases | 20 |
meconium passage | 20 |
na channels | 20 |
primary motor | 20 |
mrc sum | 20 |
medium supplemented | 20 |
asian countries | 20 |
venous blood | 20 |
systematic review | 20 |
inhibition assay | 20 |
higher concentrations | 20 |
component analysis | 20 |
kidney cells | 20 |
virus strain | 20 |
humoral immune | 20 |
previous findings | 20 |
research activities | 20 |
metropolitan institute | 20 |
apical surface | 20 |
nasal swabs | 20 |
case series | 20 |
medical centre | 20 |
human seasonal | 20 |
luteal cells | 20 |
maternal blood | 20 |
ibd patients | 20 |
activated protein | 20 |
adult male | 20 |
synaptic vesicles | 20 |
advax adjuvant | 20 |
first century | 20 |
versus ae | 20 |
health disparities | 20 |
rna expression | 20 |
following infection | 20 |
healthy control | 20 |
cftr trafficking | 20 |
ivig treatment | 20 |
two independent | 20 |
three days | 20 |
elevated levels | 20 |
low temperature | 20 |
pulse sensing | 20 |
isolation rate | 20 |
intranasal administration | 20 |
distal motor | 20 |
untreated cells | 20 |
tangential flow | 20 |
onset preeclampsia | 20 |
host immune | 20 |
cancer institute | 20 |
deep transitions | 20 |
nih grant | 20 |
cardiovascular diseases | 20 |
dna nanoparticles | 20 |
biofilm formation | 20 |
various types | 20 |
inner ear | 20 |
circulating levels | 20 |
cycle arrest | 20 |
tumour progression | 20 |
neurons showed | 20 |
czech republic | 20 |
sample preparation | 20 |
functional studies | 20 |
ozone treatment | 20 |
young children | 20 |
protein production | 19 |
nasal swab | 19 |
lactation period | 19 |
channel function | 19 |
novel method | 19 |
years ago | 19 |
aneurysmal subarachnoid | 19 |
treatment significantly | 19 |
studies indicated | 19 |
previously showed | 19 |
reported using | 19 |
plasma aea | 19 |
therapeutic effects | 19 |
disease course | 19 |
glycogen content | 19 |
cancer progression | 19 |
polyclonal antibody | 19 |
graphpad prism | 19 |
san jose | 19 |
immunohistochemical staining | 19 |
nih grants | 19 |
cigarette smoke | 19 |
patients developed | 19 |
pdm viruses | 19 |
sequence data | 19 |
well defined | 19 |
candidate genes | 19 |
male rats | 19 |
good outcome | 19 |
adult rats | 19 |
may act | 19 |
epidermal nerve | 19 |
life sciences | 19 |
kg body | 19 |
neuraminidase inhibitor | 19 |
growth medium | 19 |
mrna level | 19 |
city university | 19 |
war i | 19 |
world bank | 19 |
effective treatment | 19 |
may suggest | 19 |
novel influenza | 19 |
using elisa | 19 |
fos expression | 19 |
grip strength | 19 |
identified patients | 19 |
small size | 19 |
immunosorbent assay | 19 |
control samples | 19 |
barrier function | 19 |
oseltamivir resistance | 19 |
inflammatory markers | 19 |
cell patch | 19 |
synapse formation | 19 |
host response | 19 |
mice lacking | 19 |
ion channel | 19 |
immunofluorescence staining | 19 |
gene transcription | 19 |
deep transition | 19 |
immunized macaques | 19 |
diagnostic tests | 19 |
synaptic inputs | 19 |
unbiased ccfr | 19 |
expression system | 19 |
patients showed | 19 |
experimental data | 19 |
per ml | 19 |
quality improvement | 19 |
japan science | 19 |
spatial resolution | 19 |
preterm labour | 19 |
chiba university | 19 |
great powers | 19 |
limited number | 19 |
ca influx | 19 |
pancreatic insufficiency | 19 |
resistive pulse | 19 |
child health | 19 |
dominant negative | 19 |
normal subjects | 19 |
biological processes | 19 |
large evs | 19 |
myeloid cells | 19 |
magnetic beads | 19 |
studies demonstrate | 19 |
acid changes | 19 |
na gene | 19 |
stress response | 19 |
one hour | 19 |
strains isolated | 19 |
ev secretion | 19 |
short circuit | 19 |
neural progenitor | 19 |
elective cesarean | 19 |
using different | 19 |
optical imaging | 19 |
control patients | 19 |
modifier genes | 19 |
natural disasters | 19 |
human infection | 19 |
lipid rafts | 19 |
treatment options | 19 |
transfusion reactions | 19 |
cd evs | 19 |
oxide synthase | 19 |
multiple comparison | 19 |
acute inflammatory | 19 |
new method | 19 |
visual information | 19 |
nucleotide sequence | 19 |
well established | 19 |
care workers | 19 |
social mobility | 19 |
fat diet | 19 |
seven days | 19 |
findings may | 19 |
clinic visits | 19 |
takes place | 19 |
hospital care | 19 |
nipah virus | 19 |
specific igg | 19 |
ulnar nerve | 19 |
functional assays | 19 |
rabbit polyclonal | 19 |
antigenic cartography | 19 |
erk phosphorylation | 19 |
showed high | 19 |
six patients | 19 |
antibiotic resistance | 19 |
microplate reader | 19 |
dna polymerase | 19 |
functional role | 19 |
es cells | 19 |
cells derived | 19 |
oral administration | 19 |
autonomic dysfunction | 19 |
nucleotide sequences | 19 |
available data | 19 |
significant association | 19 |
oxygen saturation | 18 |
cumulative number | 18 |
different groups | 18 |
serum proteins | 18 |
sentinel ducks | 18 |
neuropathy score | 18 |
green fluorescent | 18 |
clinical care | 18 |
acid residues | 18 |
cov research | 18 |
important factor | 18 |
early phase | 18 |
us tax | 18 |
endothelial growth | 18 |
high incidence | 18 |
plasmid dna | 18 |
important implications | 18 |
corpus callosum | 18 |
function tests | 18 |
progenitor cell | 18 |
ringo spy | 18 |
cingulate cortex | 18 |
rna extracted | 18 |
risk management | 18 |
fold lower | 18 |
granule cell | 18 |
peste des | 18 |
fluor tm | 18 |
tm assay | 18 |
cells following | 18 |
tumour cell | 18 |
protease inhibitor | 18 |
msc evs | 18 |
blood donors | 18 |
embryonic day | 18 |
washed twice | 18 |
dependent increase | 18 |
cellular immune | 18 |
surface protein | 18 |
slightly lower | 18 |
genetic counseling | 18 |
medical records | 18 |
prospective observational | 18 |
serine protease | 18 |
anterior cingulate | 18 |
three decades | 18 |
one month | 18 |
fusion protein | 18 |
world economic | 18 |
soviet union | 18 |
also able | 18 |
also detected | 18 |
vaccine strains | 18 |
cell layer | 18 |
large amounts | 18 |
extracted using | 18 |
proinflammatory cytokine | 18 |
ae versus | 18 |
causative agent | 18 |
orf igg | 18 |
new therapies | 18 |
remained stable | 18 |
inflammatory diseases | 18 |
phase ii | 18 |
membrane fusion | 18 |
human uterine | 18 |
novel mechanism | 18 |
collagen i | 18 |
spike protein | 18 |
like receptors | 18 |
aged years | 18 |
induces apoptosis | 18 |
risk groups | 18 |
mice using | 18 |
glutamate receptors | 18 |
eye movements | 18 |
human pregnancy | 18 |
ovulation induction | 18 |
chronic inflammation | 18 |
turning point | 18 |
functional roles | 18 |
ev biogenesis | 18 |
ifnar ko | 18 |
missing data | 18 |
made using | 18 |
infected pbmcs | 18 |
cell population | 18 |
citation index | 18 |
purified evs | 18 |
specific markers | 18 |
cells expressed | 18 |
consecutive days | 18 |
ev size | 18 |
matrix metalloproteinases | 18 |
using trizol | 18 |
also seen | 18 |
neuronal death | 18 |
high concentration | 18 |
sandwich elisa | 18 |
emergency management | 18 |
heart failure | 18 |
blood vessels | 18 |
demand pressures | 18 |
people living | 18 |
antigenic drift | 18 |
immunocompromised patients | 18 |
dna content | 18 |
care units | 18 |
recently demonstrated | 18 |
fever virus | 18 |
regenerative medicine | 18 |
brain research | 18 |
severe respiratory | 18 |
trypan blue | 18 |
social connections | 18 |
placental abruption | 18 |
total evs | 18 |
genetic variation | 18 |
permanent residency | 18 |
respiratory failure | 18 |
different ev | 18 |
pd patients | 18 |
purified using | 18 |
powerful tool | 18 |
cells stably | 18 |
primary antibody | 18 |
test results | 18 |
inactivated influenza | 18 |
nucleotide polymorphisms | 18 |
without affecting | 18 |
fatality rate | 18 |
wallerian degeneration | 18 |
higher rate | 18 |
ovo cpg | 18 |
attenuated influenza | 18 |
reactive antibody | 18 |
machine learning | 18 |
igg antibody | 18 |
three years | 18 |
legislative council | 18 |
consecutive patients | 18 |
neuronal migration | 18 |
intracellularis infection | 18 |
related fear | 18 |
gray matter | 18 |
also expressed | 18 |
primary antibodies | 18 |
pf cells | 18 |
murine model | 18 |
risk assessment | 18 |
low molecular | 18 |
also studied | 18 |
shear stress | 18 |
therapeutic approach | 18 |
therapeutic hypothermia | 18 |
placental villous | 18 |
exact test | 18 |
severely affected | 18 |
fetal dna | 18 |
throughout pregnancy | 18 |
microvascular endothelial | 18 |
patients relative | 18 |
sore throat | 18 |
within min | 18 |
disaster risk | 18 |
inflammasome activation | 18 |
neonatal outcomes | 18 |
healthcare workers | 17 |
altered expression | 17 |
virus production | 17 |
study revealed | 17 |
cell evs | 17 |
botulinum neurotoxin | 17 |
equine coronavirus | 17 |
health service | 17 |
thyroid hormone | 17 |
hbe cells | 17 |
fiber density | 17 |
exclusion criteria | 17 |
muscle glycogen | 17 |
surface plasmon | 17 |
presynaptic terminals | 17 |
axon terminals | 17 |
throughput sequencing | 17 |
information regarding | 17 |
five days | 17 |
cap gene | 17 |
within minutes | 17 |
decreased expression | 17 |
coronavirus risk | 17 |
therapeutic effect | 17 |
imaging system | 17 |
enzymatic activity | 17 |
lower levels | 17 |
tunnel syndrome | 17 |
fusion proteins | 17 |
well documented | 17 |
obese women | 17 |
new insights | 17 |
pandemic strain | 17 |
factors may | 17 |
primary immunodeficiency | 17 |
evaluate whether | 17 |
ischemic brain | 17 |
thermofisher scientific | 17 |
growth model | 17 |
examine whether | 17 |
several years | 17 |
receptive fields | 17 |
health emergency | 17 |
first three | 17 |
petits ruminants | 17 |
expression may | 17 |
secondary bacterial | 17 |
following incubation | 17 |
bacterial pneumonia | 17 |
mean time | 17 |
naturally occurring | 17 |
test whether | 17 |
factor pcc | 17 |
male offspring | 17 |
various time | 17 |
resource allocation | 17 |
membrane expression | 17 |
respiratory pathogens | 17 |
ace expression | 17 |
gene promoter | 17 |
lymphoid tissue | 17 |
reading frame | 17 |
ca release | 17 |
coding sequence | 17 |
cortical areas | 17 |
cells express | 17 |
axon guidance | 17 |
ca channel | 17 |
international order | 17 |
investigated using | 17 |
uterine artery | 17 |
specific primers | 17 |
infection rates | 17 |
non pregnant | 17 |
post infection | 17 |
fmri study | 17 |
elisa kit | 17 |
laiv candidates | 17 |
ev samples | 17 |
cold challenge | 17 |
sensitive dye | 17 |
repeated measures | 17 |
research foundation | 17 |
cytometry analysis | 17 |
cell interactions | 17 |
virus titer | 17 |
data collected | 17 |
kidney disease | 17 |
receiving dialysis | 17 |
nk cell | 17 |
young dmd | 17 |
stress responses | 17 |
post hoc | 17 |
derived cells | 17 |
cold stress | 17 |
annual rainfall | 17 |
ae ng | 17 |
south america | 17 |
zip code | 17 |
trend toward | 17 |
wt littermates | 17 |
markers cd | 17 |
biological samples | 17 |
dynamic light | 17 |
transiently transfected | 17 |
african american | 17 |
present findings | 17 |
cftr chloride | 17 |
different methods | 17 |
motor neuron | 17 |
benzyl alcohol | 17 |
postnatal day | 17 |
physiologically relevant | 17 |
cells also | 17 |
evs secreted | 17 |
glial cell | 17 |
assess whether | 17 |
another study | 17 |
host responses | 17 |
ev uptake | 17 |
stranded rna | 17 |
cytometric analysis | 17 |
significant number | 17 |
sequence alignment | 17 |
based assays | 17 |
mouse monoclonal | 17 |
geometric mean | 17 |
average age | 17 |
receptor mrna | 17 |
science foundation | 17 |
many factors | 17 |
methods used | 17 |
preeclamptic women | 17 |
study demonstrated | 17 |
na mutation | 17 |
findings demonstrate | 17 |
ffp respirators | 17 |
financial crisis | 17 |
severe covid | 17 |
exosome isolation | 17 |
cord injury | 17 |
steady state | 17 |
fake news | 17 |
odn pre | 17 |
renal impairment | 17 |
two methods | 17 |
significantly reduce | 17 |
social networks | 17 |
reproduction number | 17 |
significantly altered | 17 |
physiological sciences | 17 |
time spent | 17 |
reduced expression | 17 |
five times | 17 |
mouse lung | 17 |
medrxiv preprint | 17 |
adult rat | 17 |
antiviral effect | 17 |
total population | 17 |
children aged | 17 |
reperfusion injury | 17 |
will present | 17 |
data will | 17 |
antigenic sites | 17 |
bile acids | 17 |
induced peripheral | 17 |
mean change | 17 |
der usa | 17 |
recent advances | 17 |
small cell | 17 |
similar trend | 17 |
drug resistant | 17 |
western europe | 17 |
domain antibodies | 17 |
organ prolapse | 17 |
eye movement | 17 |
genbank accession | 17 |
type virus | 17 |
prenatal exposure | 17 |
surgical intervention | 17 |
endometrial cancer | 17 |
noise ratio | 17 |
among others | 17 |
vivo experiments | 17 |
des petits | 17 |
binding activity | 17 |
exhausted medium | 17 |
myometrial cells | 17 |
months later | 17 |
rna virus | 17 |
high prevalence | 17 |
large scale | 17 |
inactivated vaccine | 17 |
may reduce | 17 |
er membrane | 17 |
epidemiological studies | 17 |
transcriptional regulation | 17 |
migratory ducks | 17 |
xi jinping | 17 |
markedly increased | 17 |
confocal laser | 17 |
prospective cohort | 17 |
membrane proteins | 17 |
emerging infections | 17 |
hemorrhagic fever | 16 |
protease inhibitors | 16 |
hemagglutination inhibition | 16 |
nucleotide binding | 16 |
psychological stress | 16 |
also included | 16 |
kinase inhibitor | 16 |
cellular processes | 16 |
maternal serum | 16 |
expressed proteins | 16 |
sex steroids | 16 |
way analysis | 16 |
severe preeclampsia | 16 |
alkaline phosphatase | 16 |
mitochondrial function | 16 |
pb gene | 16 |
live births | 16 |
mitochondrial trafficking | 16 |
time quantitative | 16 |
directly related | 16 |
general anesthesia | 16 |
evs containing | 16 |
bhk cells | 16 |
baseline characteristics | 16 |
alternative splicing | 16 |
note springer | 16 |
texas medical | 16 |
dengue virus | 16 |
triple negative | 16 |
greatly reduced | 16 |
disease models | 16 |
higher concentration | 16 |
two countries | 16 |
occupational health | 16 |
lung transplantation | 16 |
psychological impact | 16 |
health professionals | 16 |
plasmon resonance | 16 |
cell response | 16 |
great potential | 16 |
mg protein | 16 |
pandemic wave | 16 |
mar jan | 16 |
cell lung | 16 |
simplex virus | 16 |
diseases including | 16 |
ussing chamber | 16 |
also important | 16 |
supplementary tables | 16 |
niigata university | 16 |
cd positive | 16 |
endometrial stromal | 16 |
genome sequence | 16 |
da neurons | 16 |
academic medical | 16 |
symptomatic cases | 16 |
placental insufficiency | 16 |
identify potential | 16 |
single dose | 16 |
highly specific | 16 |
dna replication | 16 |
health protection | 16 |
cells via | 16 |
local government | 16 |
total cell | 16 |
blood loss | 16 |
population health | 16 |
antimicrobial resistance | 16 |
standard error | 16 |
promoter region | 16 |
fluid secretion | 16 |
ha cleavage | 16 |
new antiviral | 16 |
fetal body | 16 |
attack rate | 16 |
inflammatory effects | 16 |
postsynaptic currents | 16 |
significantly upregulated | 16 |
flow filtration | 16 |
starting point | 16 |
pcr product | 16 |
may offer | 16 |
private sector | 16 |
nature remains | 16 |
stock market | 16 |
cognitive impairment | 16 |
human primates | 16 |
jjav diluent | 16 |
remains neutral | 16 |
uninfected cells | 16 |
induced pluripotent | 16 |
many years | 16 |
tax burden | 16 |
nuclear power | 16 |
bacterial killing | 16 |
international politics | 16 |
two doses | 16 |
tg mice | 16 |
secondary electron | 16 |
clinical manifestations | 16 |
life sci | 16 |
mechanisms involved | 16 |
ordering agent | 16 |
basic reproductive | 16 |
proliferative enteropathy | 16 |
gradient ultracentrifugation | 16 |
study aims | 16 |
influenza vii | 16 |
circulating extracellular | 16 |
well described | 16 |
rat hippocampus | 16 |
women without | 16 |
oocyte maturation | 16 |
mass vaccination | 16 |
springer nature | 16 |
mar feb | 16 |
delayed cerebral | 16 |
results also | 16 |
considered statistically | 16 |
jurisdictional claims | 16 |
coronavirus infection | 16 |
using standard | 16 |
previous research | 16 |
experiments showed | 16 |
treated groups | 16 |
medical branch | 16 |
model systems | 16 |
public policy | 16 |
sample collection | 16 |
antibiotic use | 16 |